Immunoglobulin antibody against RSV prefusion F protein, published 8th Apr
EPO Patent Bulletin - Pharma (A61K)
Summary
Immunoglobulin antibody against RSV prefusion F protein, published 8th Apr
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN ANTIBODY AGAINST RSV PREFUSION F PROTEIN
Publication EP3313432A1 Kind: A1 Apr 08, 2026
Applicants
VIB VZW, Universiteit Gent, The United States of America, as represented by
The Secretary, Department of Health and Human
Services, Trustees of Dartmouth College
Inventors
SAELENS, Xavier, SCHEPENS, Bert, ROSSEY, Iebe, GRAHAM, Barney, MCLELLAN, Jason, GILMAN, Morgan
IPC Classifications
A61K 39/00 20060101AFI20260302BHEP C07K 16/10 20060101ALI20260302BHEP A61K 39/12 20060101ALI20260302BHEP A61P 31/14 20060101ALI20260302BHEP C07K 16/11 20260101ALI20260302BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.